This inventor holds 1 USPTO granted patent. Top assignees: Astellas Pharma Gmbh, Wakunaga Pharmaceutical Co., Ltd.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 426 
1 out of 30 
Years Active: 2007
Title: Kenji Sato: Innovator in Cephem Compounds
Introduction
Kenji Sato is a notable inventor based in Akitakata, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his work on cephem compounds. His innovative approach has led to the development of valuable compounds that have potential applications in medicine.
Latest Patents
Kenji Sato holds a patent for cephem compounds, specifically a compound of the formula [I]. This invention showcases his expertise in chemical formulations and their potential therapeutic uses. His patent is a testament to his dedication to advancing pharmaceutical science.
Career Highlights
Throughout his career, Kenji Sato has worked with prominent companies in the pharmaceutical industry. He has been associated with Astellas Pharma GmbH and Wakunaga Pharmaceutical Co., Ltd. These experiences have allowed him to collaborate with leading professionals in the field and contribute to significant advancements in drug development.
Collaborations
Kenji Sato has collaborated with esteemed colleagues, including Toshio Yamanaka and Kenji Murano. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Kenji Sato's contributions to the field of cephem compounds highlight his role as an influential inventor in the pharmaceutical industry. His work continues to inspire future innovations in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile